Verily aspires to be an independent company and is preparing employees for a life outside of Google.

Verily, the life sciences subsidiary of Alphabet Inc. GOOG GOOGL, has set a deadline to sever its ties with Google by ...

CEO Vicky Demas joined Identifeye Health, a startup building an AI-supported retinal imaging device, after stints with Google ...

There is a deadline of December 16 set for Alphabet's life sciences subsidiary Verily to cut ties to Google, according to another report. Verily has been working to remove itself from technology ...

Google’s life sciences division Verily is to play a part in an observational Parkinson’s disease study. The company is to work with Radboud University Medical Center, Radboud University in ...

Prior to that, Demas was a platform product manager at cancer testing company Grail and was one of the first five members of Google’s Life Sciences team, now known as Verily. Demas spoke with ...

Verily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors including its parent company, and Google holding firm, Alphabet.

As Apple and Google make significant strides in the digital health arena, tech leaders in the healthcare and medical device ...

Gillett is CEO and chairman of Verily, a health tech company formerly known as Google Life Science. It was spun out of Google’s moonshot factory, X, in 2015. Aiming to make health data more ...